Speaking at the Innovations in Disease Modeling online symposium, Steven Broadbent delivered his talk on the use of human iPSC-derived cells in disease modeling. Never miss a story ...

CAMBRIDGE, England & EDINBURGH, Scotland & GRASSE, France, October 21, 2024--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for ...

In this eBook, Axol Bioscience provides an overview of its work with iPSC-derived cells and how this technology can support the development of better, safer therapies for patients worldwide.

CAMBRIDGE, England & EDINBURGH, Scotland & GRASSE, France, October 21, 2024--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug ...